AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

Data show how AbCellera is expanding the reach of T-cell engagers with: CD3-binding antibodies that consistently generate T-cell engagers with potent tumor-cell killing and low cytokine release across multiple tumor targets, including PSMA, B7-H4, an